A prospective open-label clinical trial of adalimumab for the treatment of hidradenitis suppurativa

International Journal of Dermatology

Volumn 49, Issue 8, 2010, Pages 950-955

  Amano, Masahiro ^a   Grant, Annika ^a   Kerdel, Francisco A ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB;

ABSENCE OF SIDE EFFECTS; ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL EVALUATION; CLINICAL TRIAL; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; ETHNICITY; FEMALE; FOLLOW UP; HUMAN; INFECTION; MALE; OUTCOME ASSESSMENT; PHASE 2 CLINICAL TRIAL; PROSPECTIVE PAYMENT; RELAPSE; SCORING SYSTEM; SUPPURATIVE HIDRADENITIS; TREATMENT DURATION; VISUAL ANALOG SCALE;

ADOLESCENT; ADULT; ANTI-INFLAMMATORY AGENTS; ANTIBODIES, MONOCLONAL; FEMALE; FOLLOW-UP STUDIES; HIDRADENITIS SUPPURATIVA; HUMANS; INJECTIONS, SUBCUTANEOUS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; TREATMENT OUTCOME; YOUNG ADULT;

EID: 77954911860     PISSN: 00119059     EISSN: 13654632     Source Type: Journal    
DOI: 10.1111/j.1365-4632.2010.04545.x     Document Type: Article

References (16)

1. Wiseman MC. Hidradenitis suppurativa: a review. Dermatol Ther 2004, 17:50-54.
2. Yu CC, Cook MG. Hidradenitis suppurativa: a disease of follicular epithelium, rather than apocrine glands. Br J Dermatol 1990, 122:763-769.
3. Rosi YL, Lowe L, Kang S. Treatment of hidradenitis suppurativa with infliximab in a patient with crohn's disease. J Dermatolog Treat 2005, 16:58-61.
4. Adams DR, Gordon KB, Devenyi AG. Severe hidradenitis suppurativa treated with infliximab infusion. Arch Dermatol 2003, 139:1540-1542.
5. Sullivan TP, Welsh E, Kerdel FA. Infliximab for hidradenitis suppurativa. Br J Dermatol 2003, 149:1046-1049.
6. Lebwohl B, Sapadin AN. Infliximab for the treatment of hidradenitis suppurativa. J Am Acad Dermatol 2003, 49:S275-S276.
7. Martinez F, Nos P, Benlloch S. Hidradenitis suppurativa and Crohn's disease: response to treatment with infliximab. Inflamm Bowel Dis 2001, 7:323-326.
8. Katsanos KH, Christodoulou DK, Tsianos EV. Axillary hidradenitis suppurativa successfully treated with infliximab in a Crohn's disease patient. Am J Gastroenterol 2002, 97:2155-2156.
9. Giamarellos-Bourboulis EJ, Pelekanou E, Antonopoulou A. An open-label phase II study of the safety and efficacy of etanercept for the therapy of hidradenitis suppurativa. Br J Dermatol 2008, 158:567-572.
10. Moul DK, Korman NJ. Severe hidradenitis suppurativa treated with adalimumab. Arch Dermatol 2006, 142:1110-1112.
11. Scheinfeld N. Treatment of coincident seronegative arthritis and hidradenitis suppurativa with adalimumab. J Am Acad Dermatol 2006, 55:163-164.
12. Yamauchi P, Mau N. Hidradenitis suppurativa managed with adalimumab. J Drugs Dermatol 2009, 8:181-183.
13. Blanco R, Martinez-Taboada VM, Villa I. Long-term successful adalimumab therapy in severe hidradenitis suppurativa. Arch Dermatol 2009, 145:580-584.
14. Lee AR, Dommasch E, Treat J. A prospective clinical trial of open-label etanercept for the treatment of hidradenitis suppurativa. J Am Acad Dermatol 60(4):565-573. Apr 2009
15. Hurley HJ. Axillary hyperhidrosis, apocrine bromhidrosis, hidradenitis suppurativa and familial bening pemphigus: surgical approach. Dermatologic Surgery 1989, 729-739. Roenigk RKRoenigk HH. eds, New York, Marcel Dekker
16. Sartorius K, Lapins J, Emtestam L. Suggestions for uniform outcome variables when reporting treatment effects in hidradenitis suppurativa. Br J Dermatol 2003, 149:211-213.